Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin
Clinical trial NCT07362030 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07362030
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-14
- Primary completion
- 2025-12-27
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.